3[4]Janson CG,McPhee SW,Francis J,et al.Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1 H-MRS) and diffusion-weighted MRI.Neuropediatrics,2006,37(4):209-221
4[5]Srikanth SG,Chandrashekar HS,Nagarajan K,et al.Restricted diffusion in Canavan disease.Childs Nerv Syst,2007,23(4):465-468
5[7]Bitto E,Bingman CA,Wesenberg GE,et al.Structure of aspartoacylase,the brain enzyme impaired in Canavan disease.Proc Natl Acad Sci USA,2007,104(2):456-461
6[8]Hershfield JR,Pattabiraman N,Madhavarao CN,Mutational analysis of aspartoacylase:implications for Canavan disease.Brain Res,2007,1148(1):1-14
4Meins M, Broekmann K, Yadav S, et al. Infantile Alexander disease: a GFAP mutalion in monozygotic twins and novei mutalions in two other patients [J]. Neuropediatries, 2002, 33: 194-198.
5Rodriguez D, Gauthier F, Bertini E,et al. Infantile Alexander disease: speclrum of GFAP mutation and genotype-phenotype correlation[J]. Am J Hum Genet, 2001,69:1134-1140.
6Knapp MS, Naidu S, Breiter SN. Alexander disease: diagnosis with MR imaging[J].Am J Neuroradial, 2001,23 (3) : 541-552.
7刘焯林,梁秀玲,张成.神经遗传病学[M].2版.北京:人民卫生出版社,2002:391.
8Srikanth SG, Chandrashekar HS, Nagarajan K, et al. Restricted diffusion in Canavan disease [J]. Childs Nerv Syst, 2007, 23 (4) :465-468.
9Bitto E, Bingman CA, Wesenberg GE, et al. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease [J]. Proc Natl Acad Sci USA,2007, 104(2) :456-461.
10Rapin I,Gravel J.“Auditory neuropathy”:physiologicand pathologic evidence calls for more diagnostic specific-ity[J].Int J Pediatr Otorhinolaryngol,2003,67(7):707-728.
